The bad news began right after the November elections. And on December 7, the Senate voted to confirm the nomination of Andrew von Eschenbach as Commissioner of the federal Food and Drug Administration (FDA). As Acting Commissioner, Esehenbach approved the over-the-counter sale of the abortion-causing
1 September 2006 Vol. 8, No. 34 Dear Colleague There is an inexpensive, low-hassle alternative to electric machines for surgical abortion. Unfortunately, manual vacuum aspirators (MVAs) are becoming more common but have never been examined by the FDA for safety. Whether you are here
25 Aug 2006 Vol. 8 / No. 33 Dear Colleague: Here are some items in the news concerning life, with facts that the news generally omitted-?and one item largely omitted altogether. Steven W. Mosher President Life in the News There have been a good number of
11 Aug 2006 Vol. 8 / No. 31 FDA Prepares Sell-Out on MAP After resisting for years feminists determined to make high-dosage steroids available to women and girls without a prescription, it seems that the Bush Administration is about to cave in to political pressure
Since the end of May 2006, Postinor II (a brand name for levonorgestrel 0.75mg) cannot be sold in Ecuador. That was the decision of the Constitutional Court after a battle of more than two years against this form of the morning-after pill (MAP). “A historic
Latin American page An Interview with Dr. Fernando Rosero A Historic Victory Against MAP In Ecuador Since the end of May 2006, Postinor II (a brand name for levonorgestrel 0.75mg) cannot be sold in Ecuador. That was the decision of the Constitutional Court after a
Commends FDA for denying Over-the-Counter Status to ‘Morning-After Pill’ For Immediate Release: For more information contact: Vince Criste: (540) 622-5240 May 12, 2004 Front Royal, VA – “The FDA is to be commended for denying over-the-counter approval of the so-called ‘morning after pill’” said Steven
May 7, 2004 Volume 6 /Number 18 Dear Colleague, On May 6, the United States Food and Drug Administration narrowly averted a public health disaster by not approving the so-called “morning after pill” (also known as “emergency contraception”) for over-the-counter use without age restriction. But
Published by Population Research Institute Research by Julie Wheeland Executive Summary In May 2004, The U.S. Food and Drug Administraion (FDA) will act on Women’s Capital Corporation/Barr Laboratories application for over-the-counter (OTC) status for so-called “emergency contraception” (EC), the morning-after pill (MAP). Opposition to OTC/MAP
April 16, 2004 Volume 6 / Number 15 Dear Colleague: Over-the-counter (OTC) availability of the morning-after pill (MAP)-so called “emergency contraception” or EC- would increase rates of abortion, disease, sexual promiscuity, and sexual violence committed against American teens. OTC/MAP means danger for American girls. Steven
The bad news began right after the November elections. And on December 7, the Senate voted to confirm the nomination of Andrew von Eschenbach as
1 September 2006 Vol. 8, No. 34 Dear Colleague There is an inexpensive, low-hassle alternative to electric machines for surgical abortion. Unfortunately, manual vacuum
25 Aug 2006 Vol. 8 / No. 33 Dear Colleague: Here are some items in the news concerning life, with facts that the news generally omitted-?and
11 Aug 2006 Vol. 8 / No. 31 FDA Prepares Sell-Out on MAP After resisting for years feminists determined to make high-dosage steroids available to
Since the end of May 2006, Postinor II (a brand name for levonorgestrel 0.75mg) cannot be sold in Ecuador. That was the decision of the
Latin American page An Interview with Dr. Fernando Rosero A Historic Victory Against MAP In Ecuador Since the end of May 2006, Postinor II (a
Commends FDA for denying Over-the-Counter Status to ‘Morning-After Pill’ For Immediate Release: For more information contact: Vince Criste: (540) 622-5240 May 12, 2004 Front Royal,
May 7, 2004 Volume 6 /Number 18 Dear Colleague, On May 6, the United States Food and Drug Administration narrowly averted a public health disaster
Published by Population Research Institute Research by Julie Wheeland Executive Summary In May 2004, The U.S. Food and Drug Administraion (FDA) will act on Women’s
April 16, 2004 Volume 6 / Number 15 Dear Colleague: Over-the-counter (OTC) availability of the morning-after pill (MAP)-so called “emergency contraception” or EC- would increase
Get our Weekly Briefing! We send out a well-researched, in-depth article on a variety of topics once a week, to large and growing English-speaking and Spanish-speaking audiences.
The Population Research Institute is 501(c)(3)
All of our PRI articles, unless otherwise noted, are released under a Creative Commons Attribution-No Derivatives license. You are free to reproduce these articles, as long as you do not change them, and you credit us as follows: “Population Research Institute, https://www.pop.org”. All the rest of the material on this site, such as pages, screens, and images, are under copyright by Population Research Institute. Please contact us for information on reuse. People pictured on this site do not thereby express agreement with our views.
